Maryam Oroujeni
- E-mail:
- maryam.oroujeni@igp.uu.se
- Visiting address:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postal address:
- Rudbecklaboratoriet
751 85 UPPSALA

Publications
Recent publications
-
Part of Bioconjugate chemistry, p. 1562-1570, 2026
- DOI for Peptide Nucleic Acid Probes for Pretargeted Affibody-Mediated Delivery of Cytotoxic Payloads to HER2-Positive Carcinoma
- Download full text (pdf) of Peptide Nucleic Acid Probes for Pretargeted Affibody-Mediated Delivery of Cytotoxic Payloads to HER2-Positive Carcinoma
-
Part of International Journal of Biological Macromolecules, 2026
- DOI for Tumour accumulation of anti-carcinoembryonic antigen affibody-albumin-binding domain fusion depends on domains' order
- Download full text (pdf) of Tumour accumulation of anti-carcinoembryonic antigen affibody-albumin-binding domain fusion depends on domains' order
-
Preclinical evaluation of an antibody-based companion diagnostic for CD44v6 expressing cancer
Part of Nuclear medicine communications, p. 401-410, 2026
- DOI for Preclinical evaluation of an antibody-based companion diagnostic for CD44v6 expressing cancer
- Download full text (pdf) of Preclinical evaluation of an antibody-based companion diagnostic for CD44v6 expressing cancer
-
Part of International Journal of Molecular Sciences, 2026
- DOI for Efficient 68Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model
- Download full text (pdf) of Efficient 68Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model
-
Part of Journal of Nuclear Medicine, p. 1105-1111, 2025
All publications
Articles in journal
-
Part of Bioconjugate chemistry, p. 1562-1570, 2026
- DOI for Peptide Nucleic Acid Probes for Pretargeted Affibody-Mediated Delivery of Cytotoxic Payloads to HER2-Positive Carcinoma
- Download full text (pdf) of Peptide Nucleic Acid Probes for Pretargeted Affibody-Mediated Delivery of Cytotoxic Payloads to HER2-Positive Carcinoma
-
Part of International Journal of Biological Macromolecules, 2026
- DOI for Tumour accumulation of anti-carcinoembryonic antigen affibody-albumin-binding domain fusion depends on domains' order
- Download full text (pdf) of Tumour accumulation of anti-carcinoembryonic antigen affibody-albumin-binding domain fusion depends on domains' order
-
Preclinical evaluation of an antibody-based companion diagnostic for CD44v6 expressing cancer
Part of Nuclear medicine communications, p. 401-410, 2026
- DOI for Preclinical evaluation of an antibody-based companion diagnostic for CD44v6 expressing cancer
- Download full text (pdf) of Preclinical evaluation of an antibody-based companion diagnostic for CD44v6 expressing cancer
-
Part of International Journal of Molecular Sciences, 2026
- DOI for Efficient 68Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model
- Download full text (pdf) of Efficient 68Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model
-
Part of Journal of Nuclear Medicine, p. 1105-1111, 2025
-
Part of ACS Pharmacology & Translational Science, p. 3509-3522, 2025
- DOI for Preclinical Positron Emission Tomography Imaging of B7-H3 Expression Using Affibody Molecules Labeled with Gallium-68
- Download full text (pdf) of Preclinical Positron Emission Tomography Imaging of B7-H3 Expression Using Affibody Molecules Labeled with Gallium-68
-
Part of Translational Oncology, 2025
- DOI for An anti-CEA affibody showing high-definition staining in human pancreatic cancer tissue sections and selective tumor targeting in vivo
- Download full text (pdf) of An anti-CEA affibody showing high-definition staining in human pancreatic cancer tissue sections and selective tumor targeting in vivo
-
Part of International Journal of Molecular Sciences, 2025
- DOI for Targeting of Epithelial Cell Adhesion Molecule-Expressing Malignant Tumors Using an Albumin-Binding Domain-Fused Designed Ankyrin Repeat Protein: Effect of the Molecular Architecture
- Download full text (pdf) of Targeting of Epithelial Cell Adhesion Molecule-Expressing Malignant Tumors Using an Albumin-Binding Domain-Fused Designed Ankyrin Repeat Protein: Effect of the Molecular Architecture
-
Part of EJNMMI Radiopharmacy and Chemistry, 2025
- DOI for Selection of the optimal chelator for labeling of DARPin Ec1 with gallium-68 for PET imaging of EpCAM expression
- Download full text (pdf) of Selection of the optimal chelator for labeling of DARPin Ec1 with gallium-68 for PET imaging of EpCAM expression
-
Part of ACS Pharmacology & Translational Science, p. 706-717, 2025
- DOI for Impact of Radiometal Chelates on In Vivo Visualization of Immune Checkpoint Protein Using Radiolabeled Affibody Molecules
- Download full text (pdf) of Impact of Radiometal Chelates on In Vivo Visualization of Immune Checkpoint Protein Using Radiolabeled Affibody Molecules
-
Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 4038-4048, 2024
- DOI for Evaluation of a novel 177Lu-labelled therapeutic Affibody molecule with a deimmunized ABD domain and improved biodistribution profile
- Download full text (pdf) of Evaluation of a novel 177Lu-labelled therapeutic Affibody molecule with a deimmunized ABD domain and improved biodistribution profile
-
Part of EJNMMI Radiopharmacy and Chemistry, 2024
- DOI for Comparison of approaches for increasing affinity of affibody molecules for imaging of B7-H3: dimerization and affinity maturation
- Download full text (pdf) of Comparison of approaches for increasing affinity of affibody molecules for imaging of B7-H3: dimerization and affinity maturation
-
Part of ACS Pharmacology & Translational Science, p. 1595-1611, 2024
- DOI for Shorter Peptide Nucleic Acid Probes Improve Affibody-Mediated Peptide Nucleic Acid-Based Pretargeting
- Download full text (pdf) of Shorter Peptide Nucleic Acid Probes Improve Affibody-Mediated Peptide Nucleic Acid-Based Pretargeting
-
Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) Fusion
Part of International Journal of Molecular Sciences, 2024
- DOI for Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) Fusion
- Download full text (pdf) of Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) Fusion
-
Part of Molecular Medicine Reports, 2024
- DOI for Reduction of renal activity retention of radiolabeled albumin binding domain-derived affinity proteins using a non-residualizing label strategy compared with a cleavable glycine-leucine-glycine-lysine-linker
- Download full text (pdf) of Reduction of renal activity retention of radiolabeled albumin binding domain-derived affinity proteins using a non-residualizing label strategy compared with a cleavable glycine-leucine-glycine-lysine-linker
-
Comparison of HER2-targeted affibody conjugates loaded with auristatin-and maytansine-derived drugs
Part of Journal of Controlled Release, p. 515-527, 2023
-
Part of Journal of Controlled Release, p. 185-195, 2023
-
Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3
Part of Nuclear Medicine and Biology, 2023
- DOI for Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3
- Download full text (pdf) of Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3
-
Part of Theranostics, p. 4858-4871, 2023
- DOI for Phase I clinical evaluation of 99mTc-labeled Affibody molecule for imaging HER2 expression in breast cancer
- Download full text (pdf) of Phase I clinical evaluation of 99mTc-labeled Affibody molecule for imaging HER2 expression in breast cancer
-
Part of Frontiers in Oncology, 2023
- DOI for 177Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry
- Download full text (pdf) of 177Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry
-
Part of International Journal of Molecular Sciences, 2023
- DOI for Preclinical Evaluation of a Novel High-Affinity Radioligand [99mTc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA)
- Download full text (pdf) of Preclinical Evaluation of a Novel High-Affinity Radioligand [99mTc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA)
-
Evaluation of an Affibody-Based Binder for Imaging of Immune Check-Point Molecule B7-H3
Part of Pharmaceutics, 2022
- DOI for Evaluation of an Affibody-Based Binder for Imaging of Immune Check-Point Molecule B7-H3
- Download full text (pdf) of Evaluation of an Affibody-Based Binder for Imaging of Immune Check-Point Molecule B7-H3
-
Part of Pharmaceutics, 2022
- DOI for Effect of Inter-Domain Linker Composition on Biodistribution of ABD-Fused Affibody-Drug Conjugates Targeting HER2
- Download full text (pdf) of Effect of Inter-Domain Linker Composition on Biodistribution of ABD-Fused Affibody-Drug Conjugates Targeting HER2
-
Part of Pharmaceutics, 2022
- DOI for Preclinical Evaluation of a New Format of Ga-68- and In-111-Labeled Affibody Molecule Z(IGF-1R:4551) for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT
- Download full text (pdf) of Preclinical Evaluation of a New Format of Ga-68- and In-111-Labeled Affibody Molecule Z(IGF-1R:4551) for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT
-
Part of International Journal of Molecular Sciences, 2022
- DOI for Direct In Vivo Comparison of 99mTc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab Therapy
- Download full text (pdf) of Direct In Vivo Comparison of 99mTc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab Therapy
-
Part of Journal of Nuclear Medicine, p. 1046-1051, 2022
-
Part of Pharmaceutics, 2021
- DOI for Targeting HER2 Expressing Tumors with a Potent Drug Conjugate Based on an Albumin Binding Domain-Derived Affinity Protein
- Download full text (pdf) of Targeting HER2 Expressing Tumors with a Potent Drug Conjugate Based on an Albumin Binding Domain-Derived Affinity Protein
-
Part of Cancers, 2021
- DOI for Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse Model
- Download full text (pdf) of Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse Model
-
Radionuclide therapy using ABD-fused ADAPT scaffold protein: Proof of Principle
Part of Biomaterials, 2021
- DOI for Radionuclide therapy using ABD-fused ADAPT scaffold protein: Proof of Principle
- Download full text (pdf) of Radionuclide therapy using ABD-fused ADAPT scaffold protein: Proof of Principle
-
Part of Pharmaceutics, 2021
- DOI for The Influence of Domain Permutations of an Albumin-Binding Domain-Fused HER2-Targeting Affibody-Based Drug Conjugate on Tumor Cell Proliferation and Therapy Efficacy
- Download full text (pdf) of The Influence of Domain Permutations of an Albumin-Binding Domain-Fused HER2-Targeting Affibody-Based Drug Conjugate on Tumor Cell Proliferation and Therapy Efficacy
-
Part of Pharmaceutics, 2021
- DOI for Affibody-Derived Drug Conjugates Targeting HER2: Effect of Drug Load on Cytotoxicity and Biodistribution
- Download full text (pdf) of Affibody-Derived Drug Conjugates Targeting HER2: Effect of Drug Load on Cytotoxicity and Biodistribution
-
Part of Pharmaceutics, 2021
- DOI for The Use of a Non-Conventional Long-Lived Gallium Radioisotope 66Ga Improves Imaging Contrast of EGFR Expression in Malignant Tumours Using DFO-ZEGFR: 2377 Affibody Molecule
- Download full text (pdf) of The Use of a Non-Conventional Long-Lived Gallium Radioisotope 66Ga Improves Imaging Contrast of EGFR Expression in Malignant Tumours Using DFO-ZEGFR: 2377 Affibody Molecule
-
Part of International Journal of Molecular Sciences, 2021
- DOI for Preclinical Evaluation of Tc-99m-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake
- Download full text (pdf) of Preclinical Evaluation of Tc-99m-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake
-
Part of Cancers, 2021
- DOI for Comparative Evaluation of Novel Lu-177-Labeled PNA Probes for Affibody-Mediated PNA-Based Pretargeting
- Download full text (pdf) of Comparative Evaluation of Novel Lu-177-Labeled PNA Probes for Affibody-Mediated PNA-Based Pretargeting
-
Part of Molecules, 2020
- DOI for Investigation of a Pharmacological Approach for Reduction of Renal Uptake of Radiolabeled ADAPT Scaffold Protein
- Download full text (pdf) of Investigation of a Pharmacological Approach for Reduction of Renal Uptake of Radiolabeled ADAPT Scaffold Protein
-
Part of Pharmaceutics, 2019
- DOI for Evaluation of Tumor-Targeting Properties of an Antagonistic Bombesin Analogue RM26 Conjugated with a Non-Residualizing Radioiodine Label Comparison with a Radiometal-Labelled Counterpart
- Download full text (pdf) of Evaluation of Tumor-Targeting Properties of an Antagonistic Bombesin Analogue RM26 Conjugated with a Non-Residualizing Radioiodine Label Comparison with a Radiometal-Labelled Counterpart
-
Part of European journal of pharmaceutics and biopharmaceutics, p. 109-120, 2019
- DOI for Selection of the optimal macrocyclic chelators for labeling with 111In and 68Ga improves contrast of HER2 imaging using engineered scaffold protein ADAPT6
- Download full text (pdf) of Selection of the optimal macrocyclic chelators for labeling with 111In and 68Ga improves contrast of HER2 imaging using engineered scaffold protein ADAPT6
-
Part of European journal of pharmaceutics and biopharmaceutics, p. 37-48, 2019
- DOI for Comparative evaluation of dimeric and monomeric forms of ADAPT scaffold protein for targeting of HER2-expressing tumours
- Download full text (pdf) of Comparative evaluation of dimeric and monomeric forms of ADAPT scaffold protein for targeting of HER2-expressing tumours
-
PP15 89Zr-Siderophore-Affibody conjugates for imaging EGFR expression
Part of EJNMMI Research, 2018
-
Part of Amino Acids, p. 981-994, 2018
- DOI for Influence of composition of cysteine-containing peptide-based chelators on biodistribution of 99mTc-labeled anti-EGFR affibody molecules
- Download full text (pdf) of Influence of composition of cysteine-containing peptide-based chelators on biodistribution of 99mTc-labeled anti-EGFR affibody molecules
-
Part of CELLS, 2018
- DOI for Preclinical Evaluation of [Ga-68]Ga-DFO-ZEGFR:2377: A Promising Affibody-Based Probe for Noninvasive PET Imaging of EGFR Expression in Tumors
- Download full text (pdf) of Preclinical Evaluation of [Ga-68]Ga-DFO-ZEGFR:2377: A Promising Affibody-Based Probe for Noninvasive PET Imaging of EGFR Expression in Tumors
-
Part of Molecular Pharmaceutics, p. 175-185, 2018
- DOI for Cyclic versus Noncyclic Chelating Scaffold for Zr-89-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression
- Download full text (pdf) of Cyclic versus Noncyclic Chelating Scaffold for Zr-89-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression
-
Part of Progress in organic coatings, p. 154-161, 2018
-
Part of Journal of Nuclear Medicine, p. 1092-1098, 2018
-
Selection of the most optimal ADAPT6-based probe for imaging of HER2 using PET and SPECT
Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018
-
Optimized Molecular Design of ADAPT-Based HER2-Imaging Probes Labeled with 111In and 68Ga
Part of Molecular Pharmaceutics, p. 2674-2683, 2018
-
Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018
-
Part of European Journal of Nuclear Medicine and Molecular Imaging, 2017
-
Part of International journal of oncology, p. 2285-2293, 2016
- DOI for Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR: 2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator
- Download full text (pdf) of Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR: 2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator
-
Imaging of EGFR Expression Using 99mTC-Labelled ZEGFR:2377 Affibody Molecule
Part of European Journal of Nuclear Medicine and Molecular Imaging, 2016